Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Vice Stocks to Buy Ahead of a Possible Recession

By Josh Enomoto, InvestorPlace Contributor

As recession clouds gather, savvy investors are hedging their bets with compelling vice stocks that might ride out the storm.

7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio

By Josh Enomoto, InvestorPlace Contributor

Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game.

Lucid (LCID) Stock Pops on Saudi Arabia Factory Opening

By Josh Enomoto, InvestorPlace Contributor

Although Lucid Group announced a milestone achievement with its new facility, LCID stock still presents a credibility challenge.

NET Stock Alert: Cloudflare Announces Partnerships With AI Giants

By Josh Enomoto, InvestorPlace Contributor

With Cloudflare inking several key partnerships to bolster AI capabilities, NET stock is interesting but also requires careful consideration.

CR Group Just Sold More Shares of T2 Biosystems (TTOO) Stock

By Josh Enomoto, InvestorPlace Contributor

Despite T2 Biosystems disclosing positive product news, TTOO stock has suffered significant insider selling, posing major risks.

Load More